Cite
Piperdi S, Austin-Page L, Geller D, et al. β-Catenin Does Not Confer Tumorigenicity When Introduced into Partially Transformed Human Mesenchymal Stem Cells. Sarcoma. 2012;2012:164803doi: 10.1155/2012/164803.
Piperdi, S., Austin-Page, L., Geller, D., Ahluwalia, M., Gorlick, S., Gill, J., Park, A., Zhang, W., Li, N., Chung, S. H., & Gorlick, R. (2012). β-Catenin Does Not Confer Tumorigenicity When Introduced into Partially Transformed Human Mesenchymal Stem Cells. Sarcoma, 2012164803. https://doi.org/10.1155/2012/164803
Piperdi, Sajida, et al. "β-Catenin Does Not Confer Tumorigenicity When Introduced into Partially Transformed Human Mesenchymal Stem Cells." Sarcoma vol. 2012 (2012): 164803. doi: https://doi.org/10.1155/2012/164803
Piperdi S, Austin-Page L, Geller D, Ahluwalia M, Gorlick S, Gill J, Park A, Zhang W, Li N, Chung SH, Gorlick R. β-Catenin Does Not Confer Tumorigenicity When Introduced into Partially Transformed Human Mesenchymal Stem Cells. Sarcoma. 2012;2012:164803. doi: 10.1155/2012/164803. Epub 2012 Oct 18. PMID: 23125530; PMCID: PMC3483784.
Copy
Download .nbib